DAFNA Capital Management »

Newamsterdam Pharma Co Nv shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $640k 20k 32.01

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Stereotaxis Com New (STXS)
Day One Biopharmaceuticals I (DAWN)
AtriCure (ATRC)
Ideaya Biosciences (IDYA)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Compass Pathways Sponsored Ads (CMPS)
Nektar Therapeutics Com New (NKTR)
Ishares Nasdaq Biotech Indx Etf (IBB)
Arcus Biosciences Incorporated (RCUS)
Neurocrine Biosciences (NBIX)
Larimar Therapeutics (LRMR)
Bicara Therapeutics (BCAX)

View all positions for DAFNA Capital Management

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Capital World Investors
RA Capital Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
FMR
Wellington Management Company
Deerfield Management Company
Viking Global Investors
Duquesne Family Office
Polar Capital Holdings
Jennison Associates
Medicxi Ventures Management
Henderson Group
Westfield Capital Management Company

View all funds holding Newamsterdam Pharma Co Nv